glp-1 kidney disease news Renal effects of receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Study uncovers how chronic kidney

MHRA calls on public to report side effects and suspected fakes during MedSafetyWeek

Medical Guidance: Always speak with a healthcare provider before discontinuing glutathione supplementation

This triggers protein kinase A, which upregulates thyroid hormone synthesis enzymes (thyroid peroxidase, sodium-iodide symporter), promoting T4 and T3 production

Ranieri M, Sciuscio M, Cortese AM, et al

Net cash provided by financing activities for the year ended December 31, 2024 was primarily due to $302.8 million of net proceeds from the issuance of our common stock in our IPO and $74.9 million of net proceeds from the sale and issuance of our Series B Convertible Preferred Stock